Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Revista Espanola De Cirugia Ortopedica Y Traumatologia
|
April 16, 2014
[Advances in bone dysplasias]
E Borrego, D M Farrington, F J Downey
Health Promotion Practice
|
February 27, 2020
Increasing the Number of Underrepresented Minority Behavioral Health Researchers Partnering With Underresourced Communities: Lessons Learned From a Pilot Research Project Program
Theresa H Cruz, Matthew E Borrego, Janet Page-Reeves
The Annals of Pharmacotherapy
|
August 5, 2016
Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review
Alex L Woersching, Matthew E Borrego, Dennis W Raisch
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Quality assessment of economic analyses of pharmacological and nutritional therapy for hyperlipidemia
Ritesh N Kumar, Dennis W Raisch, Matthew E Borrego
Expert Opinion on Drug Safety
|
June 8, 2019
Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi's) used in treatment of autoimmune diseases
C Chen, M E Borrego, M H Roberts, et al.
Journal of Medical Economics
|
August 28, 2019
Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance
Yazan K Barqawi, Matthew E Borrego, Melissa H Roberts, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 15, 2013
A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening
Vishvas Garg, Ning Yan Gu, Matthew E Borrego, et al.
Research in Social & Administrative Pharmacy : RSAP
|
July 28, 2012
Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review
Yan Cheng, Dennis W Raisch, Matthew E Borrego, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 18, 2022
Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost-Benefit Analysis
Sarah Glover, Matthew E Borrego, Gretchen M Ray, et al.
Journal of the American Pharmacists Association : Japha
|
May 23, 2007
How should we measure medication adherence in clinical trials and practice?
Matthew E Borrego, Jennifer Short, Gireesh Gupchup, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Revista Espanola De Cirugia Ortopedica Y Traumatologia
|
April 16, 2014
[Advances in bone dysplasias]
E Borrego, D M Farrington, F J Downey
Health Promotion Practice
|
February 27, 2020
Increasing the Number of Underrepresented Minority Behavioral Health Researchers Partnering With Underresourced Communities: Lessons Learned From a Pilot Research Project Program
Theresa H Cruz, Matthew E Borrego, Janet Page-Reeves
The Annals of Pharmacotherapy
|
August 5, 2016
Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review
Alex L Woersching, Matthew E Borrego, Dennis W Raisch
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
Quality assessment of economic analyses of pharmacological and nutritional therapy for hyperlipidemia
Ritesh N Kumar, Dennis W Raisch, Matthew E Borrego
Expert Opinion on Drug Safety
|
June 8, 2019
Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi's) used in treatment of autoimmune diseases
C Chen, M E Borrego, M H Roberts, et al.
Journal of Medical Economics
|
August 28, 2019
Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance
Yazan K Barqawi, Matthew E Borrego, Melissa H Roberts, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 15, 2013
A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening
Vishvas Garg, Ning Yan Gu, Matthew E Borrego, et al.
Research in Social & Administrative Pharmacy : RSAP
|
July 28, 2012
Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review
Yan Cheng, Dennis W Raisch, Matthew E Borrego, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
July 18, 2022
Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost-Benefit Analysis
Sarah Glover, Matthew E Borrego, Gretchen M Ray, et al.
Journal of the American Pharmacists Association : Japha
|
May 23, 2007
How should we measure medication adherence in clinical trials and practice?
Matthew E Borrego, Jennifer Short, Gireesh Gupchup, et al.
Page
of 5